Number of the records: 1
Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice
Title Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice Author Novotný Ladislav 1955- SAVEXONK - Ústav experimentálnej onkológie SAV Co-authors Rauko Peter 1944- SAVEXONK - Ústav experimentálnej onkológie SAV Co-authors Liska Jan Elford Howard L. Szekeres Thomas Source document Cancer Letters. Vol. 233, no. 1 (2006), p. 178-184. - : Elsevier Science Ireland Language eng - English Country NL - Netherlands Document kind rozpis článkov z periodík (rbx) Citations VERMA, Sharad - SINGH, Amit - MISHRA, Abha. Gallic acid: Molecular rival of cancer. In Environmental Toxicology and Pharmacology. ISSN 13826689, 2013-05-01, 35, 3, pp. 473-485. VASSILAKOS, Aikaterini - LEE, Yoon - VIAU, Stéphane - FENG, Ningping - JIN, Hongnan - CHAI, Viengthong - WANG, Ming - AVOLIO, Tina - WRIGHT, Jim - YOUNG, Aiping. GTI-2040 displays cooperative anti-tumor activity when combined with interferon α against human renal carcinoma xenografts. In International Journal of Oncology. ISSN 10196439, 2009-04-20, 34, 1, pp. 33-42. SHAO, J. - ZHOU, B. - CHU, Bernard - YEN, Y. Ribonucleotide reductase inhibitors and future drug design. In Current Cancer Drug Targets. ISSN 15680096, 2006-07-17, 6, 5, pp. 409-431. MANNARGUDI, Mukundan Baskar - DEB, Subrata. Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? In JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. ISSN 0171-5216, 2017, vol. 143, no. 8, pp. 1499-1529. Category ADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted) Category of document (from 2022) V3 - Vedecký výstup publikačnej činnosti z časopisu Type of document článok Year 2006 Registered in WOS Registered in SCOPUS DOI 10.1016/j.canlet.2005.03.013 
article
rok CC IF IF Q (best) JCR Av Jour IF Perc SJR SJR Q (best) CiteScore A rok vydania rok metriky IF IF Q (best) SJR SJR Q (best) 2006 2005 3.049 Q2 1.391 Q1
Number of the records: 1